Sponsor:
Medical University of South Carolina
Code:
NCT06634823
Conditions
Chronic Cough (CC)
Laryngeal Disease
Coughing
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Triamcinolone Acetonide Injectable Suspension
Saline injection
Brief summary:
Conditions
Chronic Cough (CC)
Laryngeal Disease
Coughing
Study ID
NCT06634823
Start date
Dec 2, 2024
Status verified date
Jul, 2026
Completion date
Jun 30, 2027
Anticipated
Primary completion date
Jun 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
40 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
placebo comparator: Placebo
experimental: Steroid
Interventions
Triamcinolone Acetonide Injectable Suspension
Saline injection
Primary outcome measure
Central contacts
Locations
Medical University of South Carolina
Recruiting
Charleston, South Carolina, United States, 29403
Contacts
Principal Investigator:
Lauren Howser, MD
Sponsor
Medical University of South Carolina
Last update posted
Jul 22, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Medical University of South Carolina on 2026-07-22.